Humana announced it has named health care industry veteran Jim Rechtin as president and COO of Humana, effective January 8, 2024, as part of a long-planned CEO transition. He will report to Bruce Broussard, CEO, until the latter half of 2024 at which time Broussard will step down and Rechtin will assume the CEO role. Broussard joined Humana in 2011 and assumed the role of CEO in 2013. Rechtin will lead Humana into its next chapter as part of a multi-year succession plan, with Broussard to remain as a strategic advisor to the company into 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HUM:
- Humana price target lowered to $579 from $599 at Bernstein
- Humana price target raised to $586 from $580 at Jefferies
- UnitedHealth price target raised to $531 from $529 at Jefferies
- Humana, Denver Health enter agreement for Medicare Advantage members
- GoodRx deals may add pressure for pacts on other large PBMs, says TD Cowen
